ImmunoScape offers a tech platform that allows profiling and characterization of the human immune response.
ImmunoScape's investors include UTEC - The University of Tokyo Edge Capital Partners, Anzu Partners, EDBI, Amgen Ventures, Leonardo DiCaprio.
ImmunoScape is headquartered in Singapore, Singapore.
ImmunoScape offers a tech platform that allows profiling and characterization of the human immune response.
ImmunoScape is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmunoScape — Funding & Investors." VCBacked, March 4, 2026, https://www.vcbacked.co/company/immunoscape. Accessed September 15, 2026.
VCBacked. (2026). ImmunoScape — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/immunoscape
{{cite web |title=ImmunoScape — Funding & Investors |url=https://www.vcbacked.co/company/immunoscape |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated